| A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel M Cornberg, HA Razavi, A Alberti, E Bernasconi, M Buti, C Cooper, ... Liver International 31, 30-60, 2011 | 585 | 2011 |
| Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos (t) ide therapy: a systematic review GV Papatheodoridis, P Lampertico, S Manolakopoulos, A Lok Journal of hepatology 53 (2), 348-356, 2010 | 540 | 2010 |
| PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy G Papatheodoridis, G Dalekos, V Sypsa, C Yurdaydin, M Buti, J Goulis, ... Journal of hepatology 64 (4), 800-806, 2016 | 445 | 2016 |
| The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B GV Papatheodoridis, R Idilman, GN Dalekos, M Buti, H Chi, ... Hepatology 66 (5), 1444-1453, 2017 | 306 | 2017 |
| Therapeutic strategies in the management of patients with chronic hepatitis B virus infection GV Papatheodoridis, S Manolakopoulos, G Dusheiko, AJ Archimandritis The Lancet infectious diseases 8 (3), 167-178, 2008 | 280 | 2008 |
| Outcome of hepatitis B e antigen–negative chronic hepatitis B on long‐term nucleos (t) ide analog therapy starting with lamivudine GV Papatheodoridis, E Dimou, K Dimakopoulos, S Manolakopoulos, ... Hepatology 42 (1), 121-129, 2005 | 274 | 2005 |
| Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review GV Papatheodoridis, S Manolakopoulos, YF Liaw, A Lok Journal of hepatology 57 (1), 196-202, 2012 | 239 | 2012 |
| Large balloon dilation vs. mechanical lithotripsy for the management of large bile duct stones: a prospective randomized study G Stefanidis, N Viazis, D Pleskow, S Manolakopoulos, L Theocharis, ... Official journal of the American College of Gastroenterology| ACG 106 (2 …, 2011 | 238 | 2011 |
| Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral (s … GV Papatheodoridis, S Manolakopoulos, G Touloumi, G Vourli, ... Gut 60 (8), 1109-1116, 2011 | 224 | 2011 |
| Intestinal decontamination improves liver haemodynamics in patients with alcohol‐related decompensated cirrhosis J Vlachogiannakos, AS Saveriadis, N Viazis, I Theodoropoulos, ... Alimentary pharmacology & therapeutics 29 (9), 992-999, 2009 | 197 | 2009 |
| Sustained rise of portal pressure after sclerotherapy, but not band ligation, in acute variceal bleeding in cirrhosis A Avgerinos, A Armonis, G Stefanidis, N Mathou, J Vlachogiannakos, ... Hepatology 39 (6), 1623-1630, 2004 | 197 | 2004 |
| Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir GV Papatheodoridis, GN Dalekos, C Yurdaydin, M Buti, J Goulis, ... Journal of hepatology 62 (2), 363-370, 2015 | 179 | 2015 |
| Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection D Vassilopoulos, A Apostolopoulou, E Hadziyannis, GV Papatheodoridis, ... Annals of the rheumatic diseases 69 (7), 1352-1355, 2010 | 179 | 2010 |
| Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen–negative chronic hepatitis B virus infection? GV Papatheodoridis, EK Manesis, S Manolakopoulos, IS Elefsiniotis, ... Hepatology 48 (5), 1451-1459, 2008 | 154 | 2008 |
| Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding: a prospective randomized study A Avgerinos, A Armonis, S Manolakopoulos, G Poulianos, G Rekoumis, ... Journal of hepatology 26 (5), 1034-1041, 1997 | 135 | 1997 |
| Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension S Manolakopoulos, C Triantos, J Theodoropoulos, J Vlachogiannakos, ... Journal of hepatology 51 (3), 468-474, 2009 | 130 | 2009 |
| Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial S Manolakopoulos, A Avgerinos, J Vlachogiannakos, A Armonis, N Viazis, ... Gastrointestinal endoscopy 55 (4), 470-475, 2002 | 123 | 2002 |
| Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population GV Papatheodoridis, V Sypsa, G Dalekos, C Yurdaydin, F van Boemmel, ... Journal of hepatology 68 (6), 1129-1136, 2018 | 110 | 2018 |
| Clinical course of lamivudine monotherapy in patients with decompensated cirrhosis due to HBeAg negative chronic HBV infection S Manolakopoulos, S Karatapanis, J Elefsiniotis, N Mathou, ... Official journal of the American College of Gastroenterology| ACG 99 (1), 57-63, 2004 | 108 | 2004 |
| The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference A Hatzakis, P Van Damme, K Alcorn, C Gore, M Benazzouz, S Berkane, ... Journal of viral hepatitis 20, 1-20, 2013 | 107 | 2013 |
